THERESA PERRY: Open Payments
NPI 1255845392 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,730 in 129 payments from 14 companies in 2025. Trend: 2023 $2,076 · 2024 $1,712 · 2025 $1,730
Food & beverage: $1,625Education: $104
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 29 | $360 |
| ABBVIE INC. | 25 | $236 |
| Lundbeck LLC | 16 | $178 |
| Collegium Pharmaceutical, Inc. | 21 | $172 |
| Teva Pharmaceuticals USA, Inc. | 7 | $153 |
| Corium, LLC | 8 | $129 |
| Vanda Pharmaceuticals Inc. | 4 | $104 |
| Alkermes, Inc. | 5 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
Products named: REXULTI, VRAYLAR, Jornay PM, Azstarys, FANAPT, CAPLYTA, ABILIFY ASIMTUFII, COBENFY.
Industry payments across FL — which companies pay providers there.
